Pediatric PRVs, Biosecure & Novo’s obesity miss: a BioCentury podcast

Rep. Frank Pallone’s misunderstanding of how the pediatric priority review voucher program works has been one factor undermining support for an incentive that brings new drugs to kids, argues Washington Editor Steve Usdin on the latest BioCentury This Week podcast. Usdin explains how the voucher process works and why it’s valuable to the country’s youngest patients, as well as to small biotechs and larger biopharma alike.

Usdin also discusses the latest twists and turns for the Biosecure Act as it moves through Congress. The bill, which seeks to rein in the influence of Chinese CDMOs and genomics companies in the U.S., was dealt a setback in the Senate last week when it was left out of a piece of must-pass legislation...